These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15758270)

  • 1. Summary--bone metastasis.
    Donahue HJ
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):381-2. PubMed ID: 15758270
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment.
    Vinholes J; Coleman R; Eastell R
    Cancer Treat Rev; 1996 Jul; 22(4):289-331. PubMed ID: 9025785
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the biologic significance of bone metastases using 87mSr].
    Montz R; Schneider C
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:162-3. PubMed ID: 4341190
    [No Abstract]   [Full Text] [Related]  

  • 4. Understanding bone metastases: the key to the effective treatment of prostate cancer.
    Fidler IJ
    Clin Adv Hematol Oncol; 2003 May; 1(5):278-9. PubMed ID: 16224421
    [No Abstract]   [Full Text] [Related]  

  • 5. RANKL signaling in bone physiology and cancer.
    Dougall WC
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):317-22. PubMed ID: 18685382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis of hypercalcemia associated with malignant tumors].
    François D; Body JJ; Nijs-De Wolf N; Fuss M; Gillet C; Corvilain J
    Rev Med Brux; 1987; 8(6-7):359-62. PubMed ID: 2823362
    [No Abstract]   [Full Text] [Related]  

  • 7. New results from the use of bisphosphonates in cancer patients.
    Coleman R; Gnant M
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical use of calcitonin in the treatment of osseous localizations in breast carcinoma and multiple myeloma].
    Di Benedetto G; Corsini G; Puppo F; Zavarise GM
    Clin Ter; 1981 Mar; 96(6):605-13. PubMed ID: 7285526
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism.
    Vicent S; Luis-Ravelo D; Antón I; García-Tuñón I; Borrás-Cuesta F; Dotor J; De Las Rivas J; Lecanda F
    Cancer Res; 2008 Apr; 68(7):2275-85. PubMed ID: 18381434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Markers of bone remodeling: general concepts and clinical significance for skeletal lesions in oncologic patients].
    Liubimova NV; Kushlinskiĭ NE
    Vopr Onkol; 2001; 47(1):18-33. PubMed ID: 11317531
    [No Abstract]   [Full Text] [Related]  

  • 11. [A comprehensive diagnostic approach to tumor metastases in the skeleton. VI. The bone marrow in the metastatic process in malignant neoplasms].
    Bek V; Kolár J; Hermanská Z; Janko L; Hausner P; Stĕpán J; Konopásek B; Nový F
    Cas Lek Cesk; 1987 Aug; 126(34):1064-8. PubMed ID: 3664576
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate cancer cell survival pathways activated by bone metastasis microenvironment.
    Tenta R; Sotiriou E; Pitulis N; Thyphronitis G; Koutsilieris M
    J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):135-44. PubMed ID: 15951629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone metastases of malignant tumors. Pathophysiology of bone metastases].
    Bek V; Stĕpán J; Kolár J; Hausner P; Konopásek B; Nový F; Janko L
    Cas Lek Cesk; 1985 Feb; 124(5):130-5. PubMed ID: 3971398
    [No Abstract]   [Full Text] [Related]  

  • 14. The critical role of the bone microenvironment in cancer metastases.
    Casimiro S; Guise TA; Chirgwin J
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):71-81. PubMed ID: 19616059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anabolic agents and gene expression around the bone implant interface.
    Virdi AS; De Ranieri A; Kuroda S; Dai Y; Sumner DR
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):388-9. PubMed ID: 15758273
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biphosphonates as a treatment for arresting metastasis. A new indication?].
    Azuri J; Halabe A
    Harefuah; 1998 Dec; 135(11):522-4. PubMed ID: 10911470
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenesis of bone metastasis: a review.
    Raubenheimer EJ; Noffke CE
    J Oral Pathol Med; 2006 Mar; 35(3):129-35. PubMed ID: 16454807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates for breast cancer: questions answered, questions remaining.
    Layman R; Olson K; Van Poznak C
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):341-67. PubMed ID: 17512453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DMP1--a key regulator in mineralized matrix formation.
    George A; Ramachandran A; Albazzaz M; Ravindran S
    J Musculoskelet Neuronal Interact; 2007; 7(4):308. PubMed ID: 18094486
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I; Kousidou OCh; Karamanos NK
    In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.